NOT FOR
RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA,
NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF
THE EUROPEAN ECONOMIC AREA ("EEA"), OR ANY OTHER JURISDICTION
WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A
VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE
THE IMPORTANT NOTICE AT THE END OF THIS
ANNOUNCEMENT.
THE
COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR
MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS
ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN
THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL
SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS
AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF SCANCELL HOLDINGS
PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS
ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE
ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT IS FOR
INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART
OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF
AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF SCANCELL
HOLDINGS PLC.
4 December 2024
Scancell Holdings plc
("Scancell" or the "Company")
Retail Offer for up to £1
million
Scancell Holdings plc (AIM: SCLP),
the developer of novel immunotherapies for the
treatment of cancer, is pleased to announce a retail
offer via the Winterflood Retail Access Platform ("WRAP") to raise up to approximately £1
million (the "Retail
Offer") through the issue of new ordinary shares of 0.1
pence each in the capital of the Company ("Ordinary Shares"). Under the Retail
Offer up, to 9,523,809 new Ordinary Shares (the "Retail Offer Shares") will be made
available to existing retail shareholders at an issue price of 10.5
pence per Ordinary Share ("Issue
Price").
In addition to the Retail Offer, and as
announced today, the Company is also proposing a placing (the
"Placing") of new Ordinary
Shares to raise a minimum of £8.5 million (before expenses) through
a bookbuild process at the Issue Price. Alongside the Placing, one
of the Directors intends to participate by way of a direct
subscription with the Company for new Ordinary Shares at the Issue
Price raising approximately £20,000 (the "Subscription" and together with the
Placing and Retail Offer, the "Capital Raise"). If the Retail Offer is taken
up in full, the aggregate gross proceeds of the Capital Raise will
be approximately £9 million.
The Issue Price represents a discount of
approximately 22.2 per cent. to the mid-market closing price of an
Ordinary Share on 4 December 2024 (being the latest practicable
date prior to this announcement).
A separate announcement has been made regarding
the Placing and Subscription, setting out the terms of the Placing
and the reasons for the Placing and the Subscription and use of
proceeds. The net proceeds of the Retail Offer will be used
to provide further working capital and balance sheet
strength.
For the avoidance of doubt, the Retail Offer is
not part of the Placing or the Subscription. Completion of the
Retail Offer is conditional, inter alia, upon the completion of the
Placing but not the Subscription; completion of the Placing is not
conditional on any or all of the Retail Offer being subscribed
for.
The Capital Raise is conditional on the new
Ordinary Shares being admitted to trading on AIM ("Admission"). It is anticipated that
Admission will become effective and that dealings in the new
Ordinary Shares will commence on AIM, at 8.00 a.m. on 10 December
2024.
Retail
Offer
The Company values its retail shareholder base
and believes that it is appropriate to provide its existing retail
shareholders in the United Kingdom the opportunity to participate
in the Retail Offer.
Therefore, the Company is making the Retail
Offer open to eligible investors in the United Kingdom, being
existing shareholders of Scancell, following release of this
announcement and through certain financial
intermediaries.
Existing shareholders can contact their broker
or wealth manager to participate in the Retail Offer.
The Retail Offer is expected to close at 9.00
a.m. on 9 December 2024. Eligible shareholders should note that
financial intermediaries may have earlier closing times. The result
of the Retail Offer is expected to be announced by the Company on
or around 9 December
2024.
Retail brokers wishing to participate in the
Retail Offer on behalf of existing retail shareholders, should
contact wrap@winterflood.com.
To be eligible to participate in the Retail
Offer, applicants must be a customer of a participating
intermediary and, as at the date hereof or will be, prior to
placing an order for Retail Offer Shares, shareholders in the
Company which may include individuals aged 18 years or over,
companies and other bodies corporate, partnerships, trusts,
associations and other unincorporated organisations.
There is a minimum subscription of £100 per
investor under the Retail Offer. The terms and conditions on which
investors subscribe will be provided by the relevant financial
intermediaries including relevant commission or fee
charges.
The Company reserves the right to scale back
any order under the Retail Offer at its discretion. The Company
reserves the right to reject any application for subscription under
the Retail Offer without giving any reason for such
rejection.
It is vital to note that once an application
for Retail Offer Shares has been made and accepted via an
intermediary, it cannot be withdrawn.
The Retail Offer Shares will, when issued, be
credited as fully paid and will rank pari passu in all respects with
existing Ordinary Shares including the right to receive all
dividends and other distributions declared, made or paid after
their date of issue.
It is a term of the Retail Offer that the total
value of the Retail Offer Shares available for subscription at the
Issue Price does not exceed £1,000,000.
The Retail Offer is offered in the United
Kingdom under the exemption from the requirement to publish a
prospectus in section 86(1)(e) of FSMA. As such, there is no need
for publication of a prospectus pursuant to the Prospectus
Regulation Rules of the Financial Conduct Authority, or for
approval of the same by the Financial Conduct Authority. The Retail
Offer is not being made into any jurisdiction other than the United
Kingdom.
No offering document, prospectus or admission
document has been or will be prepared or submitted to be approved
by the Financial Conduct Authority (or any other authority) in
relation to the Retail Offer, and investors' commitments will be
made solely on the basis of the information contained in this
announcement and information that has been published by or on
behalf of the Company prior to the date of this announcement by
notification to a Regulatory Information Service in accordance with
the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules, the Market Abuse Regulation (EU Regulation No.
596/2014) ("MAR") and MAR
as it forms part of United Kingdom law by virtue of the European
Union (Withdrawal) Act 2018 (as amended).
Investors
should make their own investigations into the merits of an
investment in the Company. Nothing in this announcement amounts to
a recommendation to invest in the Company or amounts to investment,
taxation or legal advice.
It should be noted that a subscription for
Retail Offer Shares and investment in the Company carries a
number of risks. Investors should take independent advice
from a person experienced in advising on investment in securities
such as the Retail Offer Shares if they are in any
doubt.
An investment in the Company will place capital
at risk. The value of investments, and any income, can go down as
well as up, so investors could get back less than the amount
invested.
Neither past performance nor any forecasts
should be considered a reliable indicator of future
results.
For Further
Information, please contact:
Scancell
Holdings plc
|
+44 (0) 20
3709 5700
|
Phil L'Huillier, CEO
Professor Lindy Durrant,
CSO
Dr Jean-Michel Cosséry,
Non-Executive Chairman
|
|
|
Panmure
Liberum Limited (Joint Bookrunner, Joint Broker
and Nominated Advisor)
|
+44 (0) 20
7886 2500
|
Emma Earl, Will Goode, Mark Rogers
(Corporate Finance)
Rupert Dearden (Corporate
Broking)
|
|
WG Partners LLP (Joint Bookrunner and Joint
Broker)
David Wilson, Claes Spang, Satheesh
Nadarajah, Erland Sternby
|
+44 (0) 20
3705 9330
|
|
|
ICR Healthcare
Mary-Jane Elliott, Angela Gray,
Lindsey Neville
|
+44 (0) 20
3709 5700
scancell@icrhealthcare.com
|
Winterflood
Retail Access Platform
|
WRAP@winterflood.com
|
Joe Winkley, Sophia Bechev
|
0203 100
0286
|
Further information on the Company can be found
on its website at www.scancell.co.uk.
The Company's LEI is
2138008RXEG856SNP666.
This announcement should be read in its
entirety. In particular, the information in the "Important Notices"
section of the announcement should be read and
understood.
Important
Notices
The content of this announcement, which has
been prepared by and is the sole responsibility of the
Company.
This announcement and the information contained
herein is not for release, publication or distribution, directly or
indirectly, in whole or in part, in or into or from the United
States (including its territories and possessions, any state of the
United States and the District of Columbia (the "United States" or "US")), Australia, Canada, New Zealand,
Japan, the Republic of South Africa, any member state of the EEA or
any other jurisdiction where to do so might constitute a violation
of the relevant laws or regulations of such
jurisdiction.
The Retail Offer Shares have not been and will
not be registered under the US Securities Act of 1933, as amended
(the "US Securities Act")
or under the applicable state securities laws of the United States
and may not be offered or sold directly or indirectly in or into
the United States. No public offering of the Retail Offer Shares is
being made in the United States. The Retail Offer Shares are being
offered and sold outside the United States in "offshore transactions", as defined in,
and in compliance with, Regulation S under the US Securities Act
("Regulation S") to non-US
persons (within the meaning of Regulation S).
This announcement does not constitute an offer
to sell or issue or a solicitation of an offer to buy or subscribe
for Retail Offer Shares in the United States, Australia, Canada,
New Zealand, Japan, the Republic of South Africa, any member state
of the EEA or any other jurisdiction in which such offer or
solicitation is or may be unlawful. No public offer of the
securities referred to herein is being made in any such
jurisdiction.
The distribution of this announcement may be
restricted by law in certain jurisdictions and persons into whose
possession any document or other information referred to herein
comes should inform themselves about and observe any such
restriction. Any failure to comply with these restrictions may
constitute a violation of the securities laws of any such
jurisdiction.
WRAP is a proprietary technology platform owned
and operated by Winterflood Securities Ltd (registered address at
Riverbank House, 2 Swan Lane, London EC4R 3GA; FRN 141455).
Winterflood Securities Ltd ("Winterflood") is authorised and
regulated in the United Kingdom by the Financial Conduct Authority,
is acting exclusively for the Company and for no-one else and will
not regard any other person (whether or not a recipient of this
announcement) as its client in relation to the Retail Offer and
will not be responsible to anyone other than the Company for
providing the protections afforded to its clients, nor for
providing advice in connection with the Retail Offer, Admission and
the other arrangements referred to in this announcement.
The value of Ordinary Shares and the income
from them is not guaranteed and can fall as well as rise due to
stock market movements. When you sell your investment, you may get
back less than you originally invested. Figures refer to past
performance and past performance is not a reliable indicator of
future results. Returns may increase or decrease as a result of
currency fluctuations.
Certain statements in this announcement are
forward-looking statements which are based on the Company's
expectations, intentions and projections regarding its future
performance, anticipated events or trends and other matters that
are not historical facts. These forward-looking statements, which
may use words such as "aim", "anticipate", "believe", "intend",
"estimate", "expect" and words of similar meaning, include all
matters that are not historical facts. These forward-looking
statements involve risks, assumptions and uncertainties that could
cause the actual results of operations, financial condition,
liquidity and dividend policy and the development of the industries
in which the Company's businesses operate to differ materially from
the impression created by the forward-looking statements. These
statements are not guarantees of future performance and are subject
to known and unknown risks, uncertainties and other factors that
could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. Given
those risks and uncertainties, prospective investors are cautioned
not to place undue reliance on forward-looking
statements.
These forward-looking statements speak only as
at the date of this announcement and cannot be relied upon as a
guide to future performance. The Company and Winterflood expressly
disclaim any obligation or undertaking to update or revise any
forward-looking statements contained herein to reflect actual
results or any change in the assumptions, conditions or
circumstances on which any such statements are based unless
required to do so by the Financial Conduct Authority, London Stock
Exchange plc or applicable law.
The information in this announcement is for
background purposes only and does not purport to be full or
complete. None of Winterflood or any of its affiliates, accepts any
responsibility or liability whatsoever for, or makes any
representation or warranty, express or implied, as to this
announcement, including the truth, accuracy or completeness of the
information in this announcement (or whether any information has
been omitted from the announcement) or any other information
relating to the Company or associated companies, whether written,
oral or in a visual or electronic form, and howsoever transmitted
or made available or for any loss howsoever arising from any use of
the announcement or its contents or otherwise arising in connection
therewith. Winterflood and its affiliates, accordingly disclaim all
and any liability whether arising in tort, contract or otherwise
which they might otherwise be found to have in respect of this
announcement or its contents or otherwise arising in connection
therewith.
Any indication in this announcement of the
price at which the Ordinary Share have been bought or sold in the
past cannot be relied upon as a guide to future performance.
Persons needing advice should consult an independent financial
adviser. No statement in this announcement is intended to be a
profit forecast and no statement in this announcement should be
interpreted to mean that earnings or target dividend per share of
the Company for the current or future financial years would
necessarily match or exceed the historical published earnings or
dividends per share of the Company.
Neither the content of the Company's website
(or any other website) nor the content of any website accessible
from hyperlinks on the Company's website (or any other website) is
incorporated into or forms part of this announcement. The Retail
Offer Shares to be issued or sold pursuant to the Retail Offer will
not be admitted to trading on any stock exchange other than London
Stock Exchange plc.
It is further noted that the Retail Offer is
only open to investors in the United Kingdom who fall within
Article 43 of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (which includes an
existing member of the Company).
Panmure Liberum Limited, which is authorised
and regulated by the FCA in the United Kingdom, is acting as
Nominated Adviser, joint bookrunner and joint broker to the Company
in connection with the Placing. Panmure Liberum Limited has not
authorised the contents of, or any part of, this announcement, and
no liability whatsoever is accepted by Panmure Liberum Limited for
the accuracy of any information or opinions contained in this
announcement or for the omission of any material information. The
responsibilities of Panmure Liberum Limited as the Company's
Nominated Adviser under the AIM Rules for Companies and the AIM
Rules for Nominated Advisers are owed solely to London Stock
Exchange plc and are not owed to the Company or to any director or
shareholder of the Company or any other person, in respect of its
decision to acquire shares in the capital of the Company in
reliance on any part of this announcement, or otherwise.
WG Partners LLP, which is authorised
and regulated by the FCA in the United Kingdom, is acting as joint
bookrunner and joint broker to the Company in connection with the
Placing. WG Partners LLP has not authorised the contents of, or any
part of, this announcement, and no liability whatsoever is accepted
by WG Partners LLP for the accuracy of any information or opinions
contained in this announcement or for the omission of any material
information. No representation or warranty, express or implied, is
or will be made as to, or in relation to, and no responsibility or
liability is or will be accepted by WG Partners LLP or by any of
its affiliates or agents as to, or in relation to, the accuracy or
completeness of this announcement or any other written or oral
information made available to or publicly available to any
interested party or its advisers, and any liability therefor is
expressly disclaimed.